Circle Pharma
Focus: Circle Pharma is a newly public pharmaceutical company (founded 2024) headquartered in South San Francisco, specializing in macrocyclic therapeutics with focus on oncology, metabolic diseases, and cardiovascular indications.
Profile data last refreshed 3h ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
0
About Circle Pharma
AI assessmentNot HiringNo open roles listed right now. Follow Circle Pharma to get notified when they start hiring — the background below is worth knowing for when they do.
Generated by Claude from Circle Pharma's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Data completeness
3/9 — Basic
Company HealthSolid
Pipeline
Early-stage
9 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Circle Safe System Use During Pulmonary Vein Ablation
Atrial FibrillationClinical Trials (1)
NCT07820631First-in-Human Study of the Circle Safe System for Diaphragm Response Monitoring During Pulmonary Vein Ablation
N/AHelp build intelligence for Circle Pharma
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.